RNA interference: New drugs on the horizon

Drug Discovery Today

Volumn 10, Issue 19, 2005, Pages 1266-1267

  Bradbury, Jane ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLODEXTRIN; DOUBLE STRANDED RNA; MACROGOL; SMALL INTERFERING RNA;

CELL ACTIVITY; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG FORMULATION; ENCAPSULATION; GENE EXPRESSION; GENE SILENCING; GENE TARGETING; GENETIC CONSERVATION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIPID BILAYER; MOLECULAR MECHANICS; NONHUMAN; NOTE; ONCOGENE; PROTEIN SYNTHESIS; RNA DEGRADATION; RNA INTERFERENCE; TUMOR GROWTH; VIRUS INFECTION;

EID: 26244440400     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(05)03615-9     Document Type: Short Survey

References (4)

1. Morrissey D.V. Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs Nat. Biotechnol. 23 2005 1002 1007
2. Ryther R.C. siRNA therapeutics: big potential from small RNAs Gene Ther. 12 2005 5 11
3. Morrissey D.V. Activity of stabilized short interfering RNA in a mouse model of hepatitis B virus replication Hepatology 41 2005 1349 1356
4. Song E. Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors Nat. Biotechnol. 23 2005 709 717